Caffeine versus theophylline for apnea of prematurity: A randomised controlled trial

Journal of Paediatrics and Child Health

Volumn 45, Issue 10, 2009, Pages 587-592

  Skouroliakou, Maria ^a   Bacopoulou, Flora ^b   Markantonis, Sophia L ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b Faculty of Pharmacy   (Greece)

Author keywords

Apnea of prematurity; Caffeine; Methylxanthines; Theophylline

Indexed keywords

AMINOPHYLLINE; CAFFEINE; CAFFEINE CITRATE; THEOPHYLLINE;

ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN APNEA; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

APNEA; BRONCHODILATOR AGENTS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG THERAPY, COMBINATION; GREECE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RECURRENCE; THEOPHYLLINE;

EID: 70349966129     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2009.01570.x     Document Type: Article

References (26)

1. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997 100 : 354 359.
2. Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI, Charles BG. Periextubation caffeine in preterm neonates: a randomized dose response trial. J. Paediatr. Child Health 2003 39 : 511 515.
3. Lee TC, Charles B, Steer P, Flenady V, Shearman A. Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin. Pharmacol. Ther. 1997 61 : 628 640.
4. Scanlon JEM, Chin KC, Morgan MEI, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline for neonatal apnoea? Arch. Dis. Child. 1992 67 : 425 428.
5. Aranda JV, Cook CE, Gorman W et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J. Pediatr. 1979 94 : 663 668.
6. Steer P, Flenady V, Shearman A et al. High-dose caffeine citrate for extubation of preterm infants: a randomized controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2004 89 : F499 503.
7. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics 2002 109 : 784 787.
8. Desfrere L, Olivier P, Schwendimann L, Verney C, Gressens P. Transient inhibition of astrocytogenesis in developing mouse brain following postnatal caffeine exposure. Pediatr. Res. 2007 62 : 604 609.
9. Schmidt B, Roberts RS, Davis P et al. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 2007 357 : 1893 1902.
10. Schmidt B, Roberts RS, Davis P et al. Caffeine therapy for apnea of prematurity. N. Engl. J. Med. 2006 354 : 2112 2121.
11. Natarajan G, Botica ML, Thomas R, Aranda JV. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 2007 119 : 936 940.
12. Concha Leon AE, Michienzi K, Ma CX, Hutchison AA. Serum caffeine concentrations in preterm neonates. Am. J. Perinatol. 2007 24 : 39 47.
13. Brouard C, Moriette G, Murat I et al. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants. Am. J. Dis. Child. 1985 139 : 698 700.
14. Brazier JL, Renaud H, Ribon B, Salle BL. Plasma xanthine levels in low birthweight infants treated or not treated with theophylline. Arch. Dis. Child. 1979 54 : 194 199.
15. Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV. Metabolism of theophylline to caffeine in premature newborn infants. J. Pediatr. 1979 94 : 988 993.
16. Jones R, Baillie E. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch. Dis. Child. 1979 54 : 190 193.
17. Boutroy MJ, Vert P, Royer RJ, Monin P, Royer-Morrot MJ. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J. Pediatr. 1979 94 : 996 998.
18. Lonnerholm G, Lindstrom B, Paalzow L, Sedin G. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur. J. Clin. Pharmacol. 1983 24 : 371 374.
19. Henderson-Smart DJ, Steer PA. Prophylactic methylxanthine for preventing of apnea in preterm infants. Cochrane Database Syst. Rev. 2000 2 : CD000432.
20. Thurston JH, Hauhard RE, Dirgo JA Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice. Science 1978 201 : 649 651.
21. Fredholm BB. Astra Award Lecture: adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 1995 76 : 93 101.
22. Von Poblotzki M, Rieger-Fackeldey E, Schulze A. Effects of theophylline on the pattern of spontaneous breathing in preterm infants less than 1000 g of birth weight. Early Hum. Dev. 2003 72 : 47 55.
23. Hey E. Neonatal Formulary. Northern Neonatal Pharmacopoeia, 11th edn. London, Great Britain, BMJ Books, 2000. 67,222.
24. Muttitt SC, Finer NN, Tierney AJ, Rossmann J. Neonatal apnea: diagnosis by nurse versus computer. Pediatrics 1988 82 : 713 720.
25. Bhatia J. Current options in the management of apnea of prematurity. Clin. Pediatr. 2000 39 : 327 336.
26. Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV. Biotransformation of theophylline to caffeine in premature newborn. Lancet 1978 2 : 1204 1205.